Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06139523 · ClinicalTrials.gov registry record
Optimize Pediatric OCT Imaging
A clinical trial of Glaucoma and Retinal Disease, sponsored by Duke University.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT06139523 is a study of Glaucoma and Retinal Disease that is actively recruiting participants, run by Duke University. The registered enrollment target is 30 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06139523, a study of Glaucoma and Retinal Disease, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Handheld optical coherence tomography (OCT) has become an important imaging modality to evaluate the pediatric retina. The objective of this pilot study is to compare a new contact OCT system (Theia Imaging) with an investigational noncontact OCT system (Duke Biomedical Engineering) to assess their ability to image the pediatric retina. The investigators hypothesize that the contact OCT system is superior in imaging larger areas of the retina (larger field-of-view), while it has similar resolution to image the retina substructures (non-inferior image quality).
Conditions Studied
Interventions
- DEVICE Investigational contact OCT system
- DEVICE Investigational noncontact OCT system:
Study Locations (1)
North Carolina
- Duke University Eye Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-01-24 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06139523
The ClinicalTrials.gov registry entry for NCT06139523 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (97% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Glaucoma appearing as the primary indexed condition, and to 2 interventions - of which Investigational contact OCT system is the first listed.
NCT06139523 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06139523 about?
NCT06139523 is a clinical study titled "Optimize Pediatric OCT Imaging". Handheld optical coherence tomography (OCT) has become an important imaging modality to evaluate the pediatric retina. The objective of this pilot study is to compare a new contact OCT system (Theia Imaging) with an investigational noncontact OCT system (Duke Biomedical Engineering) to assess their ...
What is the current status of trial NCT06139523?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2024-01-24. Estimated completion is 2026-12.
What conditions does trial NCT06139523 study?
This clinical trial studies the following conditions: Glaucoma, Retinal Disease, Optic Nerve Diseases.
What interventions are being tested in trial NCT06139523?
The interventions under investigation include: Investigational contact OCT system (DEVICE), Investigational noncontact OCT system: (DEVICE).
Who is sponsoring clinical trial NCT06139523?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06139523 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Functional and Structural Imaging for Glaucoma
RECRUITING
-
Topical Insulin for Glaucoma
RECRUITING · Phase 1
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 2
-
Eye Pressure Lowering Surgery
RECRUITING
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.